Christopher R. Fenimore, VP Controller at REGENERON PHARMACEUTICALS, INC. (REGN), sold 10,764 shares at $581.40 ($6.3M) on 2020-06-16, disclosed to the SEC on 2020-06-17.
Open-market sale of $6.3M REGN by VP Controller. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $587.90 | 3,670 | $2.2M | 34.0% |
| 2 | $581.40 | 112 | $65K | 1.0% |
| 3 | $581.40 | 112 | $65K | 1.0% |
| 4 | $582.69 | 18 | $10K | 0.2% |
| 5 | $583.06 | 111 | $65K | 1.0% |
| 6 | $583.06 | 111 |
| $65K |
| 1.0% |
| 7 | $584.62 | 99 | $58K | 0.9% |
| 8 | $584.62 | 99 | $58K | 0.9% |
| 9 | $585.76 | 130 | $76K | 1.2% |
| 10 | $585.76 | 130 | $76K | 1.2% |
| 11 | $586.54 | 413 | $242K | 3.8% |
| 12 | $586.54 | 413 | $242K | 3.8% |
| 13 | $587.55 | 373 | $219K | 3.5% |
| 14 | $587.55 | 373 | $219K | 3.5% |
| 15 | $588.80 | 147 | $87K | 1.4% |
| 16 | $588.80 | 147 | $87K | 1.4% |
| 17 | $590.70 | 153 | $90K | 1.4% |
| 18 | $590.70 | 153 | $90K | 1.4% |
| 19 | $591.61 | 233 | $138K | 2.2% |
| 20 | $591.61 | 233 | $138K | 2.2% |
| 21 | $592.20 | 214 | $127K | 2.0% |
| 22 | $592.20 | 214 | $127K | 2.0% |
| 23 | $593.25 | 109 | $65K | 1.0% |
| 24 | $593.25 | 109 | $65K | 1.0% |
| 25 | $594.35 | 747 | $444K | 7.0% |
| 26 | $594.35 | 747 | $444K | 7.0% |
| 27 | $595.50 | 403 | $240K | 3.8% |
| 28 | $595.50 | 403 | $240K | 3.8% |
| 29 | $596.36 | 294 | $175K | 2.8% |
| 30 | $596.36 | 294 | $175K | 2.8% |
| Total | $589.89 avg | 10,764 | $6.3M | 100% |
| Filing → |
| REGN | SELL | 2023-12-29 | $4.2M | — | Filing → |
| REGN | SELL | 2023-12-26 | $3.3M | — | Filing → |
| REGN | SELL | 2023-03-27 | $3.5M | — | Filing → |